Serum carcinoembryonic antigen (CEA) correlates with the survival time during 5-FU hepatic arterial infusion chemotherapy for unresectable colorectal hepatic metastases

International Journal of Oncology

Volumn 9, Issue 4, 1996, Pages 741-746

  Noda, Masafumi ^a   Kusunoki, Masato ^a   Yanagi, Hidenori ^a   Yamamura, Takehira ^a   Utsunomiya, Joji ^a  

^a HYOGO COLLEGE OF MEDICINE   (Japan)

Author keywords

5 FU; arterial infusion; carcinoembryonic antigen; colorectal hepatic metastasis

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; FLUOROURACIL;

ADJUVANT THERAPY; ADULT; AGED; ARTICLE; BLOOD LEVEL; CLINICAL TRIAL; COLORECTAL CARCINOMA; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; INTRAARTERIAL DRUG ADMINISTRATION; LIVER METASTASIS; MAJOR CLINICAL STUDY; MALE; MONITORING; PRIORITY JOURNAL; SURVIVAL;

EID: 0029819018     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.9.4.741     Document Type: Article

References (32)

1. Kemeny N: Review of regional therapy of liver metastases in colorectal cancer. Semin Oncol 19: 155-162, 1992.
2. Steele G Jr and Rarehuman TS: Resection of hepatic metastases from colorectal cancer. Biologic perspectives. Ann Surg 210: 127-138, 1989.
3. Kemeny N and Golbey R: A chemotherapeutic approach to colorectal carcinoma. In: Neoplasms of the Colon, Rectum and Anus. Stearns MR Jr (ed). Weley, New York, pp 155-168, 1980.
4. Lohlich J, Fine N, Perri J and Bothe A: Protracted ambulatory venous infusion of 5-fluorouracil. Amer J Clin Oncol 6: 103-107, 1983.
5. Caballero GA, Ausman RK and Queffeman EJ: Long-term, ambulatory, continuous IV infusion of 5-FU for the treatment of advanced adenocarcinomas. Cancer Treatment Rep 69: 13-15, 1985.
6. Hansen R, Queffeman E, Ausman R, Frich J, Ritch P, Schulte W, et al: Continuous systemic 5-fluorouracil infusion in advanced colorectal cancer. Results in 91 patients. J Surg Oncol 40: 177-181, 1989.
7. Izzo J, Fandi A, Villalobos W, Azli N, Bachouchi M, May Levin F, et al: Low dose protracted continuous 5-fluorouracil (5-FU) infusion in solid tumors. J Infus Chemo 4: 135-139, 1994.
8. Kemeny N, Dely V, Reichman B, et al: Intrahepatic or systemic infusion of FUDR in patients with liver metastases from colorectal carcinoma. Ann Intern Med 107: 459-465, 1987.
9. Chang AE, Schneider PD and Sugarbaker PH: A prospective randomized trial of regional versus systemic continuous 5-FUDR chemotherapy in the treatment of colorectal liver metastases. Ann Surg 206: 685-693, 1987.
10. Schwartz SI, Jones LS and McCune CS: Assessment of treatment of intrahepatic malignancies using chemotherapy via an inplantable pump. Ann Surg 201: 560-567, 1985.
11. Johnson LP and Rivkin SE: The implanted pump in metastatic colorectal cancer of the liver: risk versus benefit. Am J Surg 149: 595-598, 1985.
12. Shepard K, Levin B, Karl R, Faintuch J, DuBrow R, Hagle M, Cooper R, Beschorner J and Stablein D: Therapy for metastatic colorectal cancer with hepatic artery infusion chemotherapy using a subcutaneous implanted port. J Clin Oncol 3: 161-169, 1985.
13. Martin JK Jr, O'Connell MJ, Wieand HS, et al: Intraarterial floxuridine vs systemic fluorouracil for hepatic metastases from colorectal cancer. A randomized trial. Arch Surg 125: 1022, 1990.
14. Herrera MA, Chu TM and Holyoke ED: Carcinoembryonic antigen (CEA) as a prognostic and monitoring test in clinically complete resection of colorectal carcinoma. Ann Surg 183: 5-9, 1976.
15. Mayer RJ, Garnick MB, Steele G Jr and Zamcheck N: Carcinoembryonic antigen (CEA) as a monitor of chemotherapy in disseminated colorectal cancer. Cancer 42: 1428-1433, 1978.
16. Sugarbaker PH, Bloomer WD, Corbett ED and Chaffey JT: Carcinoembryonic antigen (CEA) monitoring of radiation therapy for colorectal cancer. Am J Roentgenol 127: 641-644, 1976.
17. Sugarbaker PH, Zamcheck N and Moore FD: Assessment of serial carcinoembryonic antigen (CEA) assays in postoperative detection of recurrent colorectal cancer. Cancer 38: 2310-2315, 1976.
18. Vider M, Kashmiri R, Meeker WR, Moses B and Maruyama Y: Carcinoembryonic antigen (CEA) monitoring in the management of radiotherapeutic and chemotherapeutic patients. Am J Roentgenol 124: 630-635, 1975.
19. Bronstein BR, Steele GD, Ensminger W, Kaplan WD, et al: The use and limitations of serial plasma carcinoembryonic antigen (CEA) levels as a monitor of changing metastatic liver tumor volume in patients receiving chemotherapy. Cancer 46: 266-272, 1980.
20. Klopp CT, et al: Fractionated intra-arterial cancer therapy with methyl-bis-aminehydrochloride. A preliminary report. Ann Surg 132: 811-832, 1950.
21. Buchwold H, Grage TB, Vassiolopoulos PP, et al: Intraarterial infusion chemotherapy for hepatic carcinoma using a totally implantable infusion pump. Cancer 45: 866-869, 1980.
22. Hohn DC, Rayner AA, Economon JS, Ignoffo RV, Lewis BJ and Stagg RJ: Toxicities and complications of implanted pump hepatic arterial and intravenous floxuridine infusion. Cancer 57: 465-470, 1986.
23. Venook AP, Stagg RJ and Lewis BJ: Regional chemotherapy for colorectal cancer metastatic to the liver. Oncology 2: 19-23, 1988.
24. Schlag P, Hohenberger P, Hölting T and Buhl K: Hepatic arterial infusion (HAI) chemotherapy for liver metastases of colorectal cancer using 5-FU. Eur J Surg Oncol 16: 99-104, 1990.
25. Thomas P and Hems DA: The hepatic clearance of circulating native and asialo carcinoembryonic antigen by the rat. Biochem Biophys Res Commun 67: 1205-1209, 1975.
26. Lokich J, Ellenberg S, Gerson B, et al: Plasma clearance of carcinoembryonic antigen following hepatic metastasectomy. J Clin Oncol 2: 462-465, 1984.
27. Kortz WJ, Myers WC, Hanks JB, et al: Hepatic resection for metastatic cancer. Ann Surg 199: 182-184, 1984.
28. Hohenberger P, Schlag P, Germeth T and Herfarth C: Pre- and postoperative carcinoembryonic antigen determinations in hepatic resection for colorectal metastases. Ann Surg 219: 135-143, 1994.
29. Moore TL, Phar P, Zamchech N, Keeley A, Gottlieb L and Kupchik HZ: Carcinoembryonic antigen (S) in liver disease. Clinical and morphological studies. Gastroenterology 63: 88-94, 1972.
30. Lurie BB, Loewenstein MS and Zamcheck N: Elevated carcinoembryonic antigen levels and biliary tract obstruction. J Am Med Assoc 233: 326-330, 1975.
31. Warr D, McKinney S and Tannoch I: Influence of measurement error on assessment of response to anticancer chemotherapy: proposal for new criteria of tumor response. J Clin Oncol 2: 1040-1046, 1984.
32. Gurland G and Johnson RO: How reliable are tumor measurements? JAMA 194: 125-130, 1965.